Related Experiment Videos
Myelination arrest demonstrated using magnetic resonance imaging in a child with type I GM1 gangliosidosis
1Department of Radiology, China Medical College Hospital, Taichung, Taiwan.
Insights
GM1 gangliosidosis in an infant caused beta-galactosidase deficiency, leading to severe neurological issues. The study highlights myelination arrest and leukomalacia as potential hallmarks of this rare genetic disorder.
Area of Science:
- Neuroscience
- Genetics
- Pediatrics
Background:
- GM1 gangliosidosis is a rare lysosomal storage disorder.
- It results from a deficiency in the beta-galactosidase enzyme.
- This deficiency impairs the breakdown of gangliosides, leading to accumulation in cells.
Observation:
- An 18-month-old girl presented with muscle stiffness, developmental delay, hepatosplenomegaly, and kyphoscoliosis.
- MRI revealed persistent T1 hyperintensity in the thalami, brainstem, and cerebellum, indicating newborn-stage myelination arrest.
- The patient also showed absent basal ganglia myelination and diffuse cerebral leukomalacia.
Findings:
- Confirmed GM1 gangliosidosis diagnosis due to beta-galactosidase deficiency.
- Identified specific neuroimaging patterns: myelination arrest and progressive leukomalacia.
- The patient's condition was fatal at 2 years of age despite supportive care.
Implications:
- Myelination arrest at birth and progressive leukomalacia may be characteristic features of GM1 gangliosidosis.
- Early neuroimaging findings can aid in diagnosing this severe pediatric neurodegenerative disease.
- Understanding these imaging biomarkers is crucial for prognosis and potential therapeutic strategies.
Abstract:
An 18-month-old girl was diagnosed as having GM1 gangliosidosis, on the basis of the clinical symptoms of muscle stiffness, developmental retardation, hepatosplenomegaly, and kyphoscoliosis and a laboratory study that revealed a deficiency in the lysosomal degradative enzyme beta-galactosidase. Magnetic resonance T1-weighted images showed persistent hyperintensity in the bilateral thalami, brainstem, and deep cerebellum at 14 and 18 months of age, indicating arrest of the myelination process in these areas, and that the arrest had occurred at the newborn stage. There was no myelination in the basal ganglia and diffuse leukomalacia developed in the cerebral hemispheres. Only supportive treatment was given; the patient died at 2 years of age. Myelination arrest at the newborn stage associated with progressive leukomalacia is a possible characteristic of GM1 gangliosidosis.